Hyaluronate sodium

Hyaluronate sodium is a small molecule pharmaceutical. It is currently being investigated in clinical studies.

Download report

Favorite

Novartis Pharmaceuticals

Events Timeline

Commercial

Clinical

Drug

Target

Variants

Financial

Trends

Safety

Events Timeline

YTD

Max

Events

FDA approval date

EMA approval date

Patent expiration date

Study first post date

Last update post date

Start date

Primary completion date

Completion date

Results first post date

Mock data
Subscribe for the real data

Commercial

Therapeutic Areas

No data

Trade Name

FDA

EMA

No data

Drug Products

FDA

EMA

New Drug Application (NDA)

Abbreviated New Drug Application (ANDA)

No data

Labels

FDA

EMA

Brand Name	Status	Last Update
acts38 boswelliagel	unapproved drug other	2022-09-07
acts38 boswelliagel (100ml)	unapproved drug other	2022-10-22
ascorbyl palmitate 2% / hyaluronic acid sodium salt 0.2% / niacinamide 5% / tretinoin 0.025%	unapproved drug other	2019-05-17
calcipotriene 0.005% / diclofenac sodium 3% / hyaluronic acid sodium salt 2% / niacinamide 2%	unapproved drug other	2019-05-06
celistar microneedling infusion	C200263	2026-06-09
clapiel hyalon serum	unapproved drug other	2015-07-24
cotta	unapproved drug other	2013-07-08
curithys	unapproved drug other	2021-12-01
deepair micro intensive magic	unapproved drug other	2016-09-18
diclofenac sodium 3% / hyaluronic acid sodium salt 2% / niacinamide 4%	unapproved drug other	2019-05-06

Show 41 more

Indications

FDA

EMA

No data

Agency Specific

FDA

EMA

No data

Patent Expiration

No data

ATC Codes

No data

HCPCS

No data

Clinical

Clinical Trials

1710 clinical trials

View more details

Mock data
Subscribe for the real data

Indications Phases 4

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Osteoarthritis	D010003	EFO_0002506	M15-M19	28	46	44	35	134	263
Knee osteoarthritis	D020370	EFO_0004616	M17	22	44	40	31	120	235
Dry eye syndromes	D015352	—	H04.12	6	12	11	26	79	131
Keratoconjunctivitis sicca	D007638	EFO_1000906	—	2	9	9	16	50	83
Periodontitis	D010518	EFO_0000649	K05.3	4	4	1	6	34	46
Cataract	D002386	EFO_0001059	H26.9	1	2	2	9	28	42
Eye diseases	D005128	EFO_0003966	H44	3	7	3	7	18	36
Syndrome	D013577	—	—	1	2	3	6	25	36
Aging	D000375	GO_0007568	R41.81	—	—	1	2	24	27
Wounds and injuries	D014947	—	T14.8	3	1	1	2	21	27

Show 135 more

Indications Phases 3

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Periodontal diseases	D010510	—	K05.6	3	3	2	—	10	15
Gingivitis	D005891	—	K05.10	1	1	4	—	7	13
Interstitial cystitis	D018856	EFO_1000869	N30.1	1	1	1	—	6	8
Type 2 diabetes mellitus	D003924	EFO_0001360	E11	—	1	1	—	7	8
Postoperative pain	D010149	—	G89.18	—	2	2	—	5	8
Carpal tunnel syndrome	D002349	EFO_0004143	G56.0	2	—	1	—	4	7
Intervertebral disc degeneration	D055959	—	—	3	1	2	—	1	7
Back pain	D001416	—	M54	1	1	1	—	3	6
Recurrence	D012008	—	—	—	2	1	—	2	5
Corneal diseases	D003316	—	H18.9	1	2	1	—	3	5

Show 50 more

Indications Phases 2

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Rotator cuff injuries	D000070636	—	M75.1	1	1	—	—	7	9
Urinary bladder neoplasms	D001749	—	C67	2	2	—	—	4	7
Cartilage diseases	D002357	EFO_0005802	M91-M94	—	2	—	—	5	7
Ulcer	D014456	MPATH_579	—	1	1	—	—	5	6
Oxidative stress	D018384	EFO_1001905	—	—	1	—	—	4	5
Diabetic retinopathy	D003930	EFO_0003770	—	—	1	—	—	4	5
Congenital abnormalities	D000013	EFO_0003915	Q89.9	1	1	—	—	4	5
Xerostomia	D014987	—	K11.7	1	1	—	—	4	5
Carcinoma	D002277	—	C80.0	2	3	—	—	—	4
Patellofemoral pain syndrome	D046788	EFO_1001092	—	—	1	—	—	3	4

Show 68 more

Indications Phases 1

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Lipodystrophy	D008060	—	E88.1	2	—	—	—	6	8
Open-angle glaucoma	D005902	EFO_0004190	H40.1	1	—	—	—	5	6
Gingival overgrowth	D019214	—	K06.1	1	—	—	—	3	4
Acute pain	D059787	—	R52	1	—	—	—	2	3
Presbyopia	D011305	—	H52.4	3	—	—	—	—	3
Gingival hyperplasia	D005885	—	—	1	—	—	—	2	3
Gingival hypertrophy	D005886	—	—	1	—	—	—	2	3
Dental pulp diseases	D003788	EFO_0009540	K04	1	—	—	—	2	3
Stomach neoplasms	D013274	EFO_0003897	C16	1	—	—	—	1	2
Intra-articular injections	D007270	—	—	1	—	—	—	1	2

Show 14 more

Indications Without Phase

Indication	MeSH	Ontology	ICD-10	Ph 1	Ph 2	Ph 3	Ph 4	Other	Total
Gastroesophageal reflux	D005764	EFO_0003948	K21	—	—	—	—	9	9
Paralysis	D010243	—	—	—	—	—	—	5	5
Vaginal diseases	D014623	—	—	—	—	—	—	5	5
Papillomavirus infections	D030361	—	—	—	—	—	—	4	4
Peptic esophagitis	D004942	EFO_1001095	—	—	—	—	—	4	4
Macular edema	D008269	—	—	—	—	—	—	4	4
Tooth loss	D016388	—	—	—	—	—	—	4	4
Rectal neoplasms	D012004	—	—	—	—	—	—	4	4
Knee injuries	D007718	—	—	—	—	—	—	4	4
Agnosia	D000377	EFO_0007136	F88	—	—	—	—	4	4

Show 283 more

Epidemiology

Epidemiological information for investigational and approved indications

View more details

Drug

General

Drug common name	Hyaluronate sodium
INN	_
Description	Hyaluronate sodium is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Classification	Small molecule
Drug class	—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)	—